Positron emission tomography with [18F]2-fluoro-D-2-deoxyglucose (FDG-PET) predicts relapse of malignant lymphoma after high-dose therapy with stem cell transplantation - Becherer, A; Mitterbauer, M; Jaeger, U; Kalhs, P; Greinix, HT; Karanikas, G; Pötzi, C; Raderer, M; Dudczak, R; Kletter, K (Leukemia, 2002)
Keywords: Adult; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy; Antineoplastic agents; Antineoplastic Combined Chemotherapy Protocols - administration & dosage; Antineoplastic Combined Chemotherapy Protocols - therapeutic use; Biological and medical sciences; Bone marrow, stem cells transplantation. Graft versus host reaction; Carmustine - administration & dosage; Chemotherapy; Chronic toxicity; Combined Modality Therapy; Combined treatments (chemotherapy of immunotherapy associated with an other treatment); Complications; Cyclophosphamide - administration & dosage; Cytarabine - administration & dosage; Deoxyglucose; Disease-Free Survival; Drug dosages; Etoposide - administration & dosage; Female; Fluorine isotopes; Fluorodeoxyglucose F18 - pharmacokinetics; Follow-Up Studies; Hematopoietic Stem Cell Transplantation - mortality; Hodgkin Disease - diagnosis; Hodgkin Disease - diagnostic imaging; Hodgkin Disease - mortality; Hodgkin Disease - therapy; Humans; Internal medicine; Leukemia; Lymphoma; Lymphoma - diagnostic imaging; Lymphoma - drug therapy; Lymphoma - mortality; Lymphoma - therapy; Lymphoma, Non-Hodgkin - diagnosis; Lymphoma, Non-Hodgkin - diagnostic imaging; Lymphoma, Non-Hodgkin - mortality; Lymphoma, Non-Hodgkin - therapy; Male; Medical prognosis; Medical schools; Medical sciences; Melphalan - administration & dosage; Middle Aged; Neoplasm Recurrence, Local; Non-Hodgkin's lymphoma; Nuclear medicine; Patients; Pharmacology. Drug treatments; Podophyllotoxin - administration & dosage; Positron emission; Positron emission tomography; Prognosis; Radiopharmaceuticals - pharmacokinetics; Remission; Remission (Medicine); Stem cell transplantation; Stem cells; Survival Analysis; Survival Rate; Tomography; Tomography, Emission-Computed; Toxicity; Transfusions. Complications. Transfusion reactions. Cell and gene therapy; Transplantation; Transplantation Conditioning - mortality; Treatment Outcome; Whole-Body Irradiation; Austria; Radionuclide study; Antineoplastic agent; Human; Relapse; Stem cell; Treatment efficiency; Hematopoietic cell; Homograft; Exploration; Hodgkin disease; Malignant hemopathy; Non Hodgkin lymphoma; Lymphoma; Chemotherapy; Treatment; Lymphoproliferative syndrome; Graft; Combined treatment; Predictive factor; High dose; Positron; Emission tomography